Results

Total Results: 1,170 records

Showing results for "patient safety indicators".
Users also searched for: quality indicators

361. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1506.pdf
     June 01, 2015 - Novartis Pharmaceuticals. 16 week efficacy and 2 year long term safety and efficacy of secukinumab … Novartis Pharmaceuticals. 16 week efficacy and 5 year long term efficacy, safety and tolerability … anti-interleukin-17a monoclonal antibody, improves active psoriatic arthritis: 24-week efficacy and safety … antibody, improves active psoriatic arthritis and inhibits radiographic progression: efficacy and safety … 17a-monoclonal-antibody-improves-active-psoriatic-arthritis-and-inhibits-radiographic-progression-efficacy-and-safety-data-from-a-phase

362. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cad-women-diagnosis_research-protocol.pdf
     June 06, 2011 - From the MCG machine, five ECG wires with electrodes are attached to the patient at the four standard … KQ 4: Are there significant safety concerns/risks (i.e., radiation exposure, access site complications … relief, and quality of life in the population of interest) (KQ 3); and whether there are significant safety … collect demographics and data needed to determine outcomes (intermediate outcomes, health outcomes, and safety … The safety outcomes will be framed to help identify radiation exposure, contrast agent-induced nephropathy

363. FRN 41 - Noninvasive Technologies for the Diagnosis of Coronary Artery Disease in Women: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cad-women-diagnosis-future_research_1.pdf
     February 01, 2013 - Recommended study design: an observational study of patients with varying patient risk profiles. … Safety concerns Insufficient 13 studies (9 good quality, 4 fair) reported data pertinent to safety … Patient Advocate We identified a patient advocate to represent the research priorities and issues from … Recommended study design: an observational study of patients with varying patient risk profiles. 7 … Artery Disease, NCT01368770, RCT of 500 patients.

364. The Incident User Design in Comparative Effectiveness Research | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/incident-user-design/research
     May 15, 2012 - That means both patient cohorts were seen by physicians who evaluated their condition and decided that … Pharmacoepidemiol Drug Safety 2007;16:329-36. 4. Ray WA. … Pharmacoepidemiol Drug Safety 2006;15:81-92. 15. UKPDS Group. … Pharmacoepidemiol Drug Safety 2004;13:695-702. 19. Hippisley-Cox J, Coupland C. … Registries for Evaluating Patient Outcomes: A User’s Guide. AHRQ Publication No. 07-EHC001-1.

365. Microsoft Word - finbody.doc (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-artery-stenosis_research-2007.pdf
     January 01, 2007 - attention on the strength and limits of evidence from research studies about the effectiveness and safety … Analytic framework for evaluating the effectiveness and safety of treatments for renal artery stenosis … A variety of indicators of the severity of ARAS and of health problems, such as poorer kidney function … The reviewed studies did not report any indicators that may predict improved outcomes. … The reviewed studies did not report any indicators that may predict improved outcomes.

366. Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/antiplatelet-treatment/research-protocol
     November 22, 2011 - whether a patient will have a bad outcome on standard clopidogrel therapy? … Which test (or combination of tests or no test) provides the best guide for whether a patient should … and over multiple measurements on the same patient), with some patients showing no platelet response … Efficacy and safety of clopidogrel pretreatment before percutaneous coronary intervention with and without … Meta-analysis of the efficacy and safety of clopidogrel plus aspirin as compared to antiplatelet monotherapy

367. Executive Summary - Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2023 Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-executive-summary-2023-update.pdf
     January 01, 2023 - In patients with chronic (mainly neuropathic) pain with short-term treatment (4 weeks to <6 months): … prescribed cannabis (1) Whole-plant cannabis, “certified 12.5% THC” (CBD NR) route determined by patient … final mean dose 16.6/15.4 mg THC/CBD/day vs. 17.2 mg THC/day None specified; based on individual patient … a Patients could choose any medicinal product they preferred in these studies. … Effectiveness, Safety, and Tolerability of Nabiximols Oromucosal Spray vs Typical Oral Long-Acting

368. Topic Coming Back CER 28 DMARDs in Children with JIA NSD _SJ Clean (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_overview.pdf
     March 27, 2014 - How do the efficacy, effectiveness, safety, and adverse effects of treatment with DMARDs differ among … Antirheumatic Drugs (DMARDs) in Children with Juvenile Idiopathic Arthritis (JIA) indicated there were new safety … activity: Active joint count (AJC) Physician global assessment of disease activity (PGA) Parent/patient

369. Evidence Summary: CER 231 Care Interventions for People Living With Dementia and Their Caregivers (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-231-dementia-interventions-evidence-summary_0.pdf
     August 01, 2020 - adaptations of the ACCESS model) may improve system-level markers, including guideline-based quality indicators … Consolidated Standards of Reporting Trials 4 statement), pre-registration of trials, data safety … [Summary for patients in Ann Intern Med. 2006 Nov 21;145(10):I39; PMID: 17116914]. … [Summary for patients in Ann Intern Med. 2006 Nov 21;145(10):I31; PMID: 17116913]. … Effectiveness and Safety of Dementia Care Management in Primary Care: A Randomized Clinical Trial.

370. Treatment of Hepatitis C Virus Infection in Adults: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c-treatment-future_research.pdf
     April 01, 2013 - Do these harms differ according to patient subgroup characteristics, including but not limited to HCV … Do these harms differ according to patient subgroup characteristics, including but not limited to HCV … Do these harms differ according to patient subgroup characteristics? … treated with pegylated interferons in Georgia Long-term SVR according to patient characteristics … , Efficacy and Pharmacokinetics of BI 201335 NA in Patient With Genotype 1 Chronic Hepatitis C

371. Knowledge Briefs: Public Deliberation | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/deliberative-methods/research
     February 01, 2013 - health issues continues to grow, particularly in response to new mandates in the United States for patient … and consumer engagement in health care research prioritization, care service delivery, and safety and

372. Topic Suggestion Description | Effective Health Care Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/for-women-in-the-postpartum-period-what-is-the-effectiveness-and-safety-of-screening-and-treatment-for-depression-please-use-the-uspstf-framework-which-considers-not-only-screening-but-followup-treatment-and-management-the-tr
     October 01, 2011 - For women in the postpartum period, what is the effectiveness and safety of screening and treatment for … What patients or group(s) of patients does your question apply to? … Are there subgroups of patients that your question might apply to? … (For example, improvements in patient symptoms or problems from treatment or diagnosis.) … Improvements in patient depressive symptoms Improvements in parenting skills Improvements in quality

373. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/phenylketonuria_research-protocol.pdf
     March 29, 2011 - dopamine in the brain.16,17 Despite potential benefits, there is uncertainty about the efficacy and safety … of the long-term use of LNAAs and the target patient population, including the appropriateness of … with PKU that merit further study.5 Like pregnant women, safety and efficacy of the use of sapropterin … Primary outcomes in patient 1. … Primary outcomes in patient 1. Decreasing Phe levels in the blood 2.

374. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-radiation_technical-brief.pdf
     November 01, 2009 - Type of cancer and patient eligibility criteria 3.b. … For many patients in whom a whole region has to be irradiated (e.g., the whole pelvis in some patients … For example, in patients with glial tumors it ranged from 5 to 39 months, whereas in patients with … Types of cancer and patient eligibility criteria 3.b. … Adverse events, harms, and safety issues reported

375. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1506.pdf
     June 01, 2015 - Experts cited the cost, need for daily injections, and unknown long-term safety profile as potential … Patients were reported to have generally tolerated the balloon well, with one early removal for patient … .”38 However, two experts anticipated lower patient acceptance.37,42 One clinical expert stated, “Patients … Perioperative safety in the longitudinal assessment of bariatric surgery. … Safety of antiobesity drugs. Ther Adv Drug Saf. 2013;4(4):171-81.

376. CER 217 Management of Infertility Evidence Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-217-infertility-evidence-summary.pdf
     May 01, 2019 - Management of Infertility Evidence Summary Purpose of Review Evaluate the comparative effectiveness and safety … Different treatments also carry different safety risks. … What are the comparative safety and effectiveness of available treatment strategies for women with … o Donor • ART o Patient o Donor Intermediate Outcomes • Time to pregnancy Adverse Effects-Patient … Clomiphene Live birth (any/ patient) 2 RCTs44,85 (909) 1 SR (9 studies, 1783 patients)103 Improvement

377. CER 217 Management of Infertility Evidence Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-217-infertility-evidence-summary.pdf
     May 01, 2019 - Management of Infertility Evidence Summary Purpose of Review Evaluate the comparative effectiveness and safety … Different treatments also carry different safety risks. … What are the comparative safety and effectiveness of available treatment strategies for women with … o Donor • ART o Patient o Donor Intermediate Outcomes • Time to pregnancy Adverse Effects-Patient … Clomiphene Live birth (any/ patient) 2 RCTs44,85 (909) 1 SR (9 studies, 1783 patients)103 Improvement

378. March 3rd Impact of Healthcare Algorithms on Racial and Ethnic Disparities in Healthcare (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/impact-healthcare-algorithms-racial-ethnic-disparities-March-3.pdf
     July 01, 2023 - function Novel risk prediction algorithm for postpartum depression Replaced race with biological indicators … Example: an algorithm to distinguish between malignant and benign moles trained on light-skinned patients … around 6 core goals: accountability, standard, v2: general transparency, fairness, reliability and safety … standardized health data and AHRQ’s efforts to effectively use those data to improve the quality and safety … of patient care

379. PKU Surveillance Assessment_CER 56_Low (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/phenylketonuria_surveillance.pdf
     January 15, 2013 - 2013 Key Findings: • All conclusions for KQ1-7 are still considered valid • No new significant safety … Is the portion of the CER that is probably or certainly out of date an issue of safety (a drug withdrawn … What is the Effectiveness of BH4 in Patients with PKU? … Efficacy and safety of BH4 before the age of 4 years in patients with mild phenylketonuria. … What is the Effectiveness of BH4 in Patients with PKU?

380. Diagnostic Errors in the Emergency Department: A Systematic Review | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/diagnostic-errors-emergency/protocol
     December 21, 2020 - Approximately how many patients does this equate to nationally in the US?  … Do different causes have differential impact on patient outcomes (i.e., harms)?  … were seen in the year 2000 or later More than 50% of the patients were seen prior to the year … Diagnostic error in the emergency department: learning from national patient safety incident report analysis … Diagnostic errors—the next frontier for patient safety.